SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $11.5M invested in Scinai Immunotherapeutics in 2020 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.6M
2
+$742K
3
+$207K
4
Morgan Stanley
Morgan Stanley
New York
+$89.4K
5
UBS Group
UBS Group
Switzerland
+$43K

Top Sellers

1
-$653K
2
-$2.29K
3
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$7.47M
2
$1.6M
3
$1.22M
4
$435K
5
$260K
6
$207K
7
$94K
8
$78K
9
$57K
10
$43K
11
$27K
12
$11K
13
$5K
14
$5K
15
–